Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosis.
McDonald ML, Manla Y, Sonnino A, Alonso M, Neicheril RK, Sanchez A, Lafave G, Armas YS, Camargo AL, Uppal D, Handa A, Wolinsky D, Rivera NT, Velez M, Baran DA, Estep JD, Snipelisky D.
McDonald ML, et al. Among authors: alonso m.
Clin Cardiol. 2024 Jun;47(6):e24298. doi: 10.1002/clc.24298.
Clin Cardiol. 2024.
PMID: 38873847
Free PMC article.